Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Y C Martin

Showing results (1-10 of 47) with videos related to

Pageof 5
Sort By:
NIDA Research Monograph|January 1, 1993
Computer design of bioactive compounds based on 3-D properties of ligandsY C Martin
Journal of Medicinal Chemistry|March 1, 1981
A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistryY C Martin
Methods in Enzymology|January 1, 1991
Computer-assisted rational drug designY C Martin
Farmaco (Societa Chimica Italiana : 1989)|May 12, 2001
Molecular diversity: how we measure it? Has it lived up to its promise?Y C Martin
Journal of Medicinal Chemistry|January 1, 1970
Electronic factors in drug-receptor interactionsY C Martin
Cancer Chemotherapy Reports. Part 2|December 1, 1974
Proceedings: Extrathermodynamic approach to drug designY C Martin
Journal of Medicinal Chemistry|June 12, 1992
3D database searching in drug designY C Martin
Journal of Combinatorial Chemistry|May 15, 2001
Diverse viewpoints on computational aspects of molecular diversityY C Martin
Journal of Medicinal Chemistry|March 12, 1999
A general and fast scoring function for protein-ligand interactions: a simplified potential approachI Muegge, Y C Martin
Journal of Medicinal Chemistry|September 1, 1971
Influence of hydrophobic character on the relative rate of oxidation of drugs by rat liver microsomesY C Martin, C Hansch
Pageof 5

Showing results (1-10 of 47) with videos related to

Sort By:
Pageof 5
NIDA Research Monograph|January 1, 1993
Computer design of bioactive compounds based on 3-D properties of ligandsY C Martin
Journal of Medicinal Chemistry|March 1, 1981
A practitioner's perspective of the role of quantitative structure-activity analysis in medicinal chemistryY C Martin
Methods in Enzymology|January 1, 1991
Computer-assisted rational drug designY C Martin
Farmaco (Societa Chimica Italiana : 1989)|May 12, 2001
Molecular diversity: how we measure it? Has it lived up to its promise?Y C Martin
Journal of Medicinal Chemistry|January 1, 1970
Electronic factors in drug-receptor interactionsY C Martin
Cancer Chemotherapy Reports. Part 2|December 1, 1974
Proceedings: Extrathermodynamic approach to drug designY C Martin
Journal of Medicinal Chemistry|June 12, 1992
3D database searching in drug designY C Martin
Journal of Combinatorial Chemistry|May 15, 2001
Diverse viewpoints on computational aspects of molecular diversityY C Martin
Journal of Medicinal Chemistry|March 12, 1999
A general and fast scoring function for protein-ligand interactions: a simplified potential approachI Muegge, Y C Martin
Journal of Medicinal Chemistry|September 1, 1971
Influence of hydrophobic character on the relative rate of oxidation of drugs by rat liver microsomesY C Martin, C Hansch
Pageof 5